1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Immuno Oncology Assays Market Highlights
2.2. Immuno Oncology Assays Market Projection
2.3. Immuno Oncology Assays Market Regional Highlights

3. Global Immuno Oncology Assays Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter’s Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.4.1. IGR-Growth Matrix Analysis by Product
3.4.2. IGR-Growth Matrix Analysis by Technology
3.4.3. IGR-Growth Matrix Analysis by Indication
3.4.4. IGR-Growth Matrix Analysis by Application
3.4.5. IGR-Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Immuno Oncology Assays Market

4. Immuno Oncology Assays Market Macro Indicator Analysis

5. Global Immuno Oncology Assays Market by Product
5.1. Consumables
5.2. Software

6. Global Immuno Oncology Assays Market by Technology
6.1. PCR
6.2. Immunoassay
6.3. NGS
6.4. Flow Cytometry
6.5. Other Technology

7. Global Immuno Oncology Assays Market by Indication
7.1. Lung Cancer
7.2. Colorectal Cancer
7.3. Melanoma
7.4. Bladder Cancer
7.5. Other Indication

8. Global Immuno Oncology Assays Market by Application
8.1. Research Applications
8.2. Clinical Diagnostics

9. Global Immuno Oncology Assays Market by Region 2019-2025
9.1. North America
9.1.1. North America Immuno Oncology Assays Market by Product
9.1.2. North America Immuno Oncology Assays Market by Technology
9.1.3. North America Immuno Oncology Assays Market by Indication
9.1.4. North America Immuno Oncology Assays Market by Application
9.1.5. North America Immuno Oncology Assays Market by Country
9.2. Europe
9.2.1. Europe Immuno Oncology Assays Market by Product
9.2.2. Europe Immuno Oncology Assays Market by Technology
9.2.3. Europe Immuno Oncology Assays Market by Indication
9.2.4. Europe Immuno Oncology Assays Market by Application
9.2.5. Europe Immuno Oncology Assays Market by Country
9.3. Asia-Pacific
9.3.1. Asia-Pacific Immuno Oncology Assays Market by Product
9.3.2. Asia-Pacific Immuno Oncology Assays Market by Technology
9.3.3. Asia-Pacific Immuno Oncology Assays Market by Indication
9.3.4. Asia-Pacific Immuno Oncology Assays Market by Application
9.3.5. Asia-Pacific Immuno Oncology Assays Market by Country
9.4. RoW
9.4.1. RoW Immuno Oncology Assays Market by Product
9.4.2. RoW Immuno Oncology Assays Market by Technology
9.4.3. RoW Immuno Oncology Assays Market by Indication
9.4.4. RoW Immuno Oncology Assays Market by Application
9.4.5. RoW Immuno Oncology Assays Market by Sub-region

10. Company Profiles and Competitive Landscape
10.1. Competitive Landscape in the Global Immuno Oncology Assays Market
10.2. Companies Profiles
10.2.1. PerkinElmer, Inc.
10.2.2. HTG Molecular Diagnostics, Inc.
10.2.3. Foundation Medicine, Inc.
10.2.4. Sartorius AG
10.2.5. NanoString Technologies, Inc.
10.2.6. Agilent Technologies
10.2.7. F. Hoffmann-La Roche AG
10.2.8. Thermo Fisher Scientific
10.2.9. Illumina, Inc
10.2.10. QIAGEN GmbH

11. Appendix
11.1. Primary Research Findings and Questionnaire